| 000 | 01665 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513170457.0 | ||
| 264 | 0 | _c19990527 | |
| 008 | 199905s 0 0 eng d | ||
| 022 | _a0264-410X | ||
| 024 | 7 |
_a10.1016/s0264-410x(98)00273-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHoppenbrouwers, K | |
| 245 | 0 | 0 |
_aPriming effect, immunogenicity and safety of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-acellular pertussis (DTaP) combination vaccine administered to infants in Belgium and Turkey. _h[electronic resource] |
| 260 |
_bVaccine _cFeb 1999 |
||
| 300 |
_a875-86 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aBelgium |
| 650 | 0 | 4 |
_aDiphtheria-Tetanus-Pertussis Vaccine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHaemophilus Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization Schedule |
| 650 | 0 | 4 | _aImmunization, Secondary |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aTetanus Toxoid _xadministration & dosage |
| 650 | 0 | 4 | _aTurkey |
| 650 | 0 | 4 |
_aVaccines, Combined _xadverse effects |
| 700 | 1 | _aKanra, G | |
| 700 | 1 | _aRoelants, M | |
| 700 | 1 | _aCeyhan, M | |
| 700 | 1 | _aVandermeulen, C | |
| 700 | 1 | _aYurdakök, K | |
| 700 | 1 | _aSilier, T | |
| 700 | 1 | _aDupuy, M | |
| 700 | 1 | _aPehlivan, T | |
| 700 | 1 | _aOzmert, E | |
| 700 | 1 | _aDesmyter, J | |
| 773 | 0 |
_tVaccine _gvol. 17 _gno. 7-8 _gp. 875-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0264-410x(98)00273-4 _zAvailable from publisher's website |
| 999 |
_c10027761 _d10027761 |
||